Treximet, a sumatriptan and naproxen combination treatment, approved for migraine

Joseph DiPiro, PharmD, FCCP, FAAAS, editor of the American Society of Health-System Pharmacists 2025 Pharmacy Forecast, discussed key themes in the forecast that will impact health-system pharmacy in 2025.

Don Arthur, RPh, discusses what lays ahead in independent pharmacy, from clinical care to success stories.

Jennifer Clements, PharmD, BCACP, BC-ADM, BCPS, CDCES, FADCES, FCCP, discussed the benefits of tirzepatide compared with semaglutide.

Learn more about the ins and outs of pharmacy ownership from the experts at First Financial Bank.

Two posters presented at the meeting looked into the topic CGMs in diabetes care.

Experts conducted a study to better understand how ambulatory care pharmacist services impacted patient outcomes, provider workload, and access to care.